
Multi-peptide research blend (GHK-Cu 50 mg · KPV 10 mg · BPC-157 10 mg · TB-500 10 mg) supplied for in-vitro research.
Read the research guide· 4 min readThe KLOW Blend brings together four synthetic research peptides frequently referenced side-by-side in in-vitro laboratory literature: GHK-Cu (copper tripeptide-1) 50 mg, KPV (a lysine–proline–valine tripeptide) 10 mg, BPC-157 (a synthetic pentadecapeptide) 10 mg and TB-500 (a synthetic thymosin β4 fragment) 10 mg, for 80 mg total peptide content per vial.
Every vial is manufactured to strict laboratory standards, HPLC-characterised per component and independently third-party tested. Pre-blending simplifies procurement for research workflows that routinely combine these four peptides.
The KLOW Blend is referenced in laboratory work involving:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every KLOW Blend vial supplied by NXT GEN RESEARCH is HPLC-characterised per component and independently third-party tested, giving researchers consistent, well-documented material for their laboratory workflow.
Lyophilised material: -20 °C. In solution: 2–8 °C; laboratory practice commonly references a working life of up to 28 days from first entry when stored correctly.
This blend is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Mitochondrial-derived peptide supplied for in-vitro laboratory research.

I am over 18 years of age. I am a professional or student researcher.
Research grade compounds · Not for human or animal consumption